Self-assembly antimicrobial peptide for treatment of multidrug-resistant bacterial infection

Xuanxuan Ma,Na Yang,Ruoyu Mao,Ya Hao,Yuanyuan Li,Ying Guo,Da Teng,Yinhua Huang,Jianhua Wang
DOI: https://doi.org/10.1186/s12951-024-02896-5
IF: 10.2
2024-11-01
Journal of Nanobiotechnology
Abstract:The wide-spreading of multidrug resistance poses a significant threat to human and animal health. Although antimicrobial peptides (AMPs) show great potential application, their instability has severely limited their clinical application. Here, self-assembled AMPs composed of multiple modules based on the principle of associating natural marine peptide N6 with ß-sheet-forming peptide were designed. It is noteworthy that one of the designed peptides, FFN could self-assemble into nanoparticles at 35.46 μM and achieve a dynamic transformation from nanoparticles to nanofibers in the presence of bacteria, resulting in a significant increase in stability in trypsin and tissues by 1.72–57.5 times compared to that of N6. Additionally, FFN exhibits a broad spectrum of antibacterial activity against multidrug-resistant (MDR) gram-positive (G + ) and gram-negative (G − ) bacteria with Minimum inhibitory concentrations (MICs) as low as 2 μM by membrane destruction and complemented by nanofiber capture. In vivo mouse mastitis infection model further confirmed the therapeutic potential and promising biosafety of the self-assembled peptide FFN, which can effectively alleviate mastitis caused by MDR Escherichia coli ( E. coli ) and Staphylococcus aureus ( S. aureus ), and eliminate pathogenic bacteria. In conclusion, the design of peptide-based nanomaterials presents a novel approach for the delivery and clinical translation of AMPs, promoting their application in medicine and animal husbandry.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?